Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4793278 | 0.87 | HDAC1 (0.60) | HDAC1HDAC6GAAL3MBTL1KMT2A | |
| SCHEMBL9155475 | 0.82 | HDAC1 (0.62) | HDAC1HDAC6GAAL3MBTL1KMT2A | |
| SCHEMBL8837264 | 0.80 | HDAC1 (0.51) | HDAC1HDAC6GAAL3MBTL1KMT2A | |
| SCHEMBL219829 | 0.80 | ALDH1A1 (0.47) | HDAC1HDAC6L3MBTL1KMT2AMEN1 | |
| SCHEMBL11667796 | 0.79 | ALDH1A1 (0.46) | L3MBTL1KMT2AMEN1ALDH1A1GLA | |
| SCHEMBL7144694 | 0.78 | GAA (0.59) | GAAL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL10536972 | 0.78 | KMT2A (0.50) | GAAKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL13645008 | 0.76 | GAA (0.53) | HDAC1HDAC6GAAL3MBTL1KMT2A | |
| SCHEMBL690247 | 0.76 | ALDH1A1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1GLA | |
| SCHEMBL11557648 | 0.76 | ALDH1A1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046386-B1 | PEPTIDE COMPOUNDS FOR THE TREATMENT OF SKELETAL MUSCLE DISORDERS ASSOCIATED WITH ION CHANNEL DYSFUNCTION | UCB PHARMA GMBH (DE) | 2014-07-23 | — | — | EP | claimed |
| US-20140128377-A1 | METHODS OF TREATING REFRACTORY REPETITIVE SEIZURES | UCB PHARMA GMBH (DE) | 2014-05-08 | — | — | US | claimed |
| US-20130316953-A1 | NEW USES FOR AMINO ACID ANTICONVULSANTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2013-11-28 | — | — | US | claimed |
| EP-2210598-B1 | Anticonvulsant amino acids for the treatment of pain | RES CORP TECHNOLOGIES INC (US) | 2013-09-18 | — | — | EP | claimed |
| US-8519183-B2 | Uses for amino acid anticonvulsants | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2013-08-27 | — | — | US | claimed |
| EP-1753415-B1 | NOVEL USE OF PEPTIDE COMPOUNDS FOR TREATING PAIN IN TRIGEMINAL NEURALGIA | UCB PHARMA GMBH (DE) | 2013-04-17 | — | — | EP | claimed |
| US-20100273716-A1 | NEW USES FOR AMINO ACID ANTICONVULSANTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2010-10-28 | — | — | US | claimed |
| US-20100273714-A1 | PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUS | SCHWARZ PHARMA AG (DE) | 2010-10-28 | — | — | US | claimed |
| US-20100260716-A1 | COMPOUNDS FOR TREATING DEMYELINATION CONDITIONS | UCB PHARMA GMBH (DE) | 2010-10-14 | — | — | US | claimed |
| EP-1695703-B1 | Anticonvulsant amino acids for the treatment of obsessive-compulsive neurosis | RES CORP TECHNOLOGIES INC (US) | 2010-08-11 | — | — | EP | claimed |
| EP-1373300-A2 | NOVEL USE OF A PEPTIDE CLASS OF COMPOUND FOR TREATING NON NEUROPATHIC INFLAMMATORY PAIN | SCHWARZ PHARMA AG (DE) | 2004-01-02 | — | — | EP | claimed |
| EP-1365787-A2 | NEW USES FOR AMINO ACID ANTICONVULSANTS FOR TREATMENT OF PAIN | Research Corporation Technologies, Inc (US) | 2003-12-03 | — | — | EP | claimed |
| US-20030171300-A1 | Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary | UCB PHARMA GMBH (DE) | 2003-09-11 | — | — | US | claimed |
| WO-2002074784-A2 | NOVEL USE OF A PEPTIDE CLASS OF COMPOUND FOR TREATING NON NEUROPATHIC INFLAMMATORY PAIN | SCHWARZ PHARMA AG (DE) | 2002-09-26 | — | — | WO | claimed |
| EP-1243262-A1 | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain | SCHWARZ PHARMA AG (DE) | 2002-09-25 | — | — | EP | claimed |
| US-20020086828-A1 | Uses for amino acid anticonvulsants | HARRIS ROBERT H (US) | 2002-07-04 | — | — | US | claimed |
| WO-2002015922-A2 | NEW USES FOR AMINO ACID ANTICONVULSANTS FOR TREATMENT OF PAIN | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| US-5378729-A | Diamide derivatives | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-01-03 | — | — | US | claimed |
| EP-0194464-B1 | AMINO ACID DERIVATIVES AND USE THEREOF FOR THE PREPARATION OF AN ANTICONVULSANT | Research Corporation Technologies, Inc. (a Delaware corp.) (US) | 1991-04-03 | — | — | EP | claimed |
| EP-0194464-A1 | Amino acid derivatives and use thereof for the preparation of an anticonvulsant | Research Corporation Technologies, Inc. (a Delaware corp.) (US) | 1986-09-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086828-A1 | Uses for amino acid anticonvulsants | SLC1A2, SLC1A1, SLC1A3 | HDAC1 1291/4885HDAC6 972/4885GAA 1506/4885 |
| US-20100273714-A1 | PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUS | VIP, VGF, PRSS12 | HDAC1 362/4885HDAC6 389/4885GAA 2774/4885 |
| US-20130316953-A1 | NEW USES FOR AMINO ACID ANTICONVULSANTS | SLC1A2, SLC1A1, SLC1A3 | HDAC1 1427/4885HDAC6 900/4885GAA 2331/4885 |
| US-20140128377-A1 | METHODS OF TREATING REFRACTORY REPETITIVE SEIZURES | GABRE, GRIK2, GABRR1 | HDAC1 463/4885HDAC6 213/4885GAA 2215/4885 |
| US-20030171300-A1 | Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary | OPRK1, OPRL1, PTGER1 | HDAC1 1676/4885HDAC6 1360/4885GAA 4419/4885 |
| US-20100273716-A1 | NEW USES FOR AMINO ACID ANTICONVULSANTS | SLC1A2, SLC1A1, SLC1A3 | HDAC1 1427/4885HDAC6 900/4885GAA 2331/4885 |
| US-20100260716-A1 | COMPOUNDS FOR TREATING DEMYELINATION CONDITIONS | PMP22, MAG, MYT1 | HDAC1 165/4885HDAC6 94/4885GAA 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.